ModelEdge

Antares Pharma, Inc.
0001016169
Filing Type8-K
Filing Date5/23/2022
Updated5/24/22, 10:22 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, End of Material Contract, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Com
EX-3.1EX-3.1
EX-3.2EX-3.2